BridgeBio Pharma LLC

13F Holdings History for BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)

Symbol: BBOT on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 13.9M shares
Security Ownership: 17.5%

BridgeBio Pharma LLC ownership in BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

2025-08-18 - BridgeBio Pharma LLC has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 13.9M shares of BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT). This represents 17.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BridgeBio Pharma LLC	17.5%		$131M	13.9M			$9.45	13D	8/11/2025	18 Aug 2025 17:41:28